Fig. 1.
The percentage of CD25+/FOXP3+/CD127 (–/low) T cells within CD3+/CD4+ T cells in patients with progesterone receptor (PR) (+) and PR (–) breast cancer tumours
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.